scholarly journals P584. Infliximab therapy for Japanese patients with ulcerative colitis: Efficacy, safety, and association between serum infliximab levels and early response in a randomized, double-blind, placebo-controlled study

2015 ◽  
Vol 9 (suppl 1) ◽  
pp. S372-S373 ◽  
Keyword(s):  
Ulcerative Colitis ◽  
Japanese Patients ◽  
Early Response ◽  
Infliximab Therapy ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

PLoS ONE ◽  
2019 ◽  
Vol 14 (4) ◽  
pp. e0215491 ◽  
Author(s):  
Satoshi Motoya ◽  
Kenji Watanabe ◽  
Haruhiko Ogata ◽  
Takanori Kanai ◽  
Toshiyuki Matsui ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Japanese Patients ◽  
Controlled Study ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

PLoS ONE ◽  
2019 ◽  
Vol 14 (2) ◽  
pp. e0212989 ◽  
Author(s):  
Satoshi Motoya ◽  
Kenji Watanabe ◽  
Haruhiko Ogata ◽  
Takanori Kanai ◽  
Toshiyuki Matsui ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Japanese Patients ◽  
Controlled Study ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study

2002 ◽  
Vol 16 (6) ◽  
pp. 1109-1116 ◽  
Author(s):  
F. Rizzello ◽  
P. Gionchetti ◽  
A. D'Arienzo ◽  
F. Manguso ◽  
G. Di Matteo ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Controlled Study ◽  
Active Ulcerative Colitis ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document